PCSK9i: proprotein convertase subtilisin/kexin type 9 inhibitor a new phase of lipid-lowering treatment
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Главный автор: | Lubaba, Anikah |
---|---|
Другие авторы: | Fariha, Luluel Maknun |
Формат: | Диссертация |
Язык: | English |
Опубликовано: |
Brac University
2024
|
Предметы: | |
Online-ссылка: | http://hdl.handle.net/10361/23252 |
Схожие документы
-
Effect of vitamin D, calcium and multiple micronutrients supplementation on lipid profile in pre-menopausal Bangladeshi garment factory workers with hypovitaminosis D
по: Islam, Md Zahirul, и др.
Опубликовано: (2017) -
Post Covid-19 health indications of Covid-19 patients
по: Khan, Tanzim
Опубликовано: (2022) -
Heart disease prediction using machine learning algorithms
по: Ali, Musfiq, и др.
Опубликовано: (2019) -
হার্ট, ব্লাড, ফুড /
по: কাসেম, এম এ -
Anti-inflammatory effect of Statins in reducing the exacerbation and mortality rates of COPD patients: a review study
по: Shomi, Iffat Ara
Опубликовано: (2019)